General MedicationsINTRAMUSCULARGeneric

HYDROXYPROGESTERONE CAPROATE

Standard Dose

1250MG/5ML (250MG/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview HYDROXYPROGESTERONE CAPROATE is listed in Drugs@FDA under application 211142 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROXYPROGESTERONE CAPROATE Form and strength SOLUTION;INTRAMUSCULAR - 1250MG/5ML (250MG/ML) Sponsor EUGIA PHARMA Submission history Latest submission status date: 2022-05-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview HYDROXYPROGESTERONE CAPROATE is listed in Drugs@FDA under application 211142 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROXYPROGESTERONE CAPROATE Form and strength SOLUTION;INTRAMUSCULAR - 1250MG/5ML (250MG/ML) Sponsor EUGIA PHARMA Submission history Latest submission status date: 2022-05-24 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.